Copyright
©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. May 6, 2017; 8(2): 127-130
Published online May 6, 2017. doi: 10.4292/wjgpt.v8.i2.127
Published online May 6, 2017. doi: 10.4292/wjgpt.v8.i2.127
Total (%) | FC ≤ 250 μg/g | FC > 250 μg/g | |
Samples | 49 | 21 (43) | 28 (57) |
Age (yr) | 12.8 | 13.3 | 12.4 |
Diagnosis | |||
CD | 21 (43) | 9 (43) | 12 (43) |
UC | 22 (45) | 10 (48) | 12 (43) |
IBD-U | 6 (12) | 2 (9) | 4 (14) |
Gender | |||
Male | 24 (49) | 8 (38) | 16 (57) |
Female | 25 (51) | 13 (62) | 12 (43) |
CRP (mg/dL) | 2.29 | 1.12 | 3.31 |
ESR (mm/h) | 25.54 | 13.09 | 34.23 |
- Citation: Rodriguez A, Yokomizo L, Christofferson M, Barnes D, Khavari N, Park KT. Correlation of rapid point-of-care vs send-out fecal calprotectin monitoring in pediatric inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2017; 8(2): 127-130
- URL: https://www.wjgnet.com/2150-5349/full/v8/i2/127.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v8.i2.127